publication . Conference object . 2019

Design and Characterization of Mutant and Wild-Type Huntingtin Proteins Produced from a Toolkit of Scalable Eukaryotic Expression Systems 2019/06/04

Harding, Rachel;
Open Access
  • Published: 04 Jun 2019
  • Publisher: Zenodo
Abstract
Dr. Harding is the recipient of the Huntington's Disease Society of America Berman Topper Career Development Fellowship which funds and supports this research, in addition to generous funding from the CHDI Foundation and the Huntington Society of Canada. The SGC is a registered charity (number 1097737) that receives funds from AbbVie, Bayer Pharma AG, Boehringer Ingelheim, Canada Foundation for Innovation, Eshelman Institute for Innovation, Genome Canada through Ontario Genomics Institute [OGI-055], Innovative Medicines Initiative (EU/EFPIA) [ULTRA-DD grant no. 115766], Janssen, Merck KGaA, Darmstadt, Germany, MSD, Novartis Pharma AG, Ontario Ministry of Researc...
Subjects
Medical Subject Headings: mental disorderscongenital, hereditary, and neonatal diseases and abnormalitiesnervous system diseasesnervous system
free text keywords: huntingtin, Huntington's disease, Protein purification, Toolkit
Download fromView all 2 versions
Open Access
Zenodo
Conference object . 2019
Provider: Datacite
Open Access
Zenodo
Conference object . 2019
Provider: Datacite
Any information missing or wrong?Report an Issue